TransMedics Group, Inc. (TMDX) Q4 2023 Earnings Results

TransMedics Group, Inc. Beats on EPS, Stock Down 6.5%

TransMedics Group's strong EPS performance indicates positive momentum, but the stock fell 6.5% following the earnings report. Investors may be concerned about the lack of revenue details and future guidance, which could lead to uncertainty in the stock's performance moving forward.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.12	N/A	+222.45%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting ongoing efforts to innovate. However, they did not provide specific guidance for future quarters.

We are pleased with our EPS performance this quarter.

Our focus remains on driving innovation and expanding our market presence.

TransMedics Group, Inc. Beats on EPS, Stock Down 6.5%

Key numbers

Management commentary

TransMedics Group, Inc.

More earnings this week

TransMedics Group, Inc. Beats on EPS, Stock Down 6.5%

Key numbers

Management commentary